Global RNAi Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global RNAi Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global RNAi Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global RNAi Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global RNAi Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global RNAi Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global RNAi Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for RNAi Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global RNAi Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna and Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
RNAi Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe RNAi Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of RNAi Therapy, with revenue, gross margin and global market share of RNAi Therapy from 2018 to 2023.
Chapter 3, the RNAi Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and RNAi Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of RNAi Therapy.
Chapter 13, to describe RNAi Therapy research findings and conclusion.
This report is a detailed and comprehensive analysis for global RNAi Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global RNAi Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global RNAi Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global RNAi Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global RNAi Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for RNAi Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global RNAi Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna and Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
RNAi Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Small Molecule Interfering Ribonucleic Acid (SiRNA)
- Microrna (MiRNA)
- Oncology
- Cardiology
- Others
- Alnylam
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Moderna
- Sanofi
- Arcturus Therapeutics
- Silence
- Sirnaomics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe RNAi Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of RNAi Therapy, with revenue, gross margin and global market share of RNAi Therapy from 2018 to 2023.
Chapter 3, the RNAi Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and RNAi Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of RNAi Therapy.
Chapter 13, to describe RNAi Therapy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of RNAi Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of RNAi Therapy by Type
1.3.1 Overview: Global RNAi Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global RNAi Therapy Consumption Value Market Share by Type in 2022
1.3.3 Small Molecule Interfering Ribonucleic Acid (SiRNA)
1.3.4 Microrna (MiRNA)
1.4 Global RNAi Therapy Market by Application
1.4.1 Overview: Global RNAi Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Oncology
1.4.3 Cardiology
1.4.4 Others
1.5 Global RNAi Therapy Market Size & Forecast
1.6 Global RNAi Therapy Market Size and Forecast by Region
1.6.1 Global RNAi Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global RNAi Therapy Market Size by Region, (2018-2029)
1.6.3 North America RNAi Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe RNAi Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific RNAi Therapy Market Size and Prospect (2018-2029)
1.6.6 South America RNAi Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa RNAi Therapy Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Alnylam
2.1.1 Alnylam Details
2.1.2 Alnylam Major Business
2.1.3 Alnylam RNAi Therapy Product and Solutions
2.1.4 Alnylam RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Alnylam Recent Developments and Future Plans
2.2 Sarepta Therapeutics
2.2.1 Sarepta Therapeutics Details
2.2.2 Sarepta Therapeutics Major Business
2.2.3 Sarepta Therapeutics RNAi Therapy Product and Solutions
2.2.4 Sarepta Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sarepta Therapeutics Recent Developments and Future Plans
2.3 Alnylam Pharmaceuticals
2.3.1 Alnylam Pharmaceuticals Details
2.3.2 Alnylam Pharmaceuticals Major Business
2.3.3 Alnylam Pharmaceuticals RNAi Therapy Product and Solutions
2.3.4 Alnylam Pharmaceuticals RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.4 Moderna
2.4.1 Moderna Details
2.4.2 Moderna Major Business
2.4.3 Moderna RNAi Therapy Product and Solutions
2.4.4 Moderna RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Moderna Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi RNAi Therapy Product and Solutions
2.5.4 Sanofi RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 Arcturus Therapeutics
2.6.1 Arcturus Therapeutics Details
2.6.2 Arcturus Therapeutics Major Business
2.6.3 Arcturus Therapeutics RNAi Therapy Product and Solutions
2.6.4 Arcturus Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Arcturus Therapeutics Recent Developments and Future Plans
2.7 Silence
2.7.1 Silence Details
2.7.2 Silence Major Business
2.7.3 Silence RNAi Therapy Product and Solutions
2.7.4 Silence RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Silence Recent Developments and Future Plans
2.8 Sirnaomics
2.8.1 Sirnaomics Details
2.8.2 Sirnaomics Major Business
2.8.3 Sirnaomics RNAi Therapy Product and Solutions
2.8.4 Sirnaomics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sirnaomics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global RNAi Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of RNAi Therapy by Company Revenue
3.2.2 Top 3 RNAi Therapy Players Market Share in 2022
3.2.3 Top 6 RNAi Therapy Players Market Share in 2022
3.3 RNAi Therapy Market: Overall Company Footprint Analysis
3.3.1 RNAi Therapy Market: Region Footprint
3.3.2 RNAi Therapy Market: Company Product Type Footprint
3.3.3 RNAi Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global RNAi Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global RNAi Therapy Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global RNAi Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global RNAi Therapy Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America RNAi Therapy Consumption Value by Type (2018-2029)
6.2 North America RNAi Therapy Consumption Value by Application (2018-2029)
6.3 North America RNAi Therapy Market Size by Country
6.3.1 North America RNAi Therapy Consumption Value by Country (2018-2029)
6.3.2 United States RNAi Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada RNAi Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico RNAi Therapy Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe RNAi Therapy Consumption Value by Type (2018-2029)
7.2 Europe RNAi Therapy Consumption Value by Application (2018-2029)
7.3 Europe RNAi Therapy Market Size by Country
7.3.1 Europe RNAi Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany RNAi Therapy Market Size and Forecast (2018-2029)
7.3.3 France RNAi Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom RNAi Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia RNAi Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy RNAi Therapy Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific RNAi Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific RNAi Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific RNAi Therapy Market Size by Region
8.3.1 Asia-Pacific RNAi Therapy Consumption Value by Region (2018-2029)
8.3.2 China RNAi Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan RNAi Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea RNAi Therapy Market Size and Forecast (2018-2029)
8.3.5 India RNAi Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia RNAi Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia RNAi Therapy Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America RNAi Therapy Consumption Value by Type (2018-2029)
9.2 South America RNAi Therapy Consumption Value by Application (2018-2029)
9.3 South America RNAi Therapy Market Size by Country
9.3.1 South America RNAi Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil RNAi Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina RNAi Therapy Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa RNAi Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa RNAi Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa RNAi Therapy Market Size by Country
10.3.1 Middle East & Africa RNAi Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey RNAi Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia RNAi Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE RNAi Therapy Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 RNAi Therapy Market Drivers
11.2 RNAi Therapy Market Restraints
11.3 RNAi Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 RNAi Therapy Industry Chain
12.2 RNAi Therapy Upstream Analysis
12.3 RNAi Therapy Midstream Analysis
12.4 RNAi Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of RNAi Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of RNAi Therapy by Type
1.3.1 Overview: Global RNAi Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global RNAi Therapy Consumption Value Market Share by Type in 2022
1.3.3 Small Molecule Interfering Ribonucleic Acid (SiRNA)
1.3.4 Microrna (MiRNA)
1.4 Global RNAi Therapy Market by Application
1.4.1 Overview: Global RNAi Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Oncology
1.4.3 Cardiology
1.4.4 Others
1.5 Global RNAi Therapy Market Size & Forecast
1.6 Global RNAi Therapy Market Size and Forecast by Region
1.6.1 Global RNAi Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global RNAi Therapy Market Size by Region, (2018-2029)
1.6.3 North America RNAi Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe RNAi Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific RNAi Therapy Market Size and Prospect (2018-2029)
1.6.6 South America RNAi Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa RNAi Therapy Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Alnylam
2.1.1 Alnylam Details
2.1.2 Alnylam Major Business
2.1.3 Alnylam RNAi Therapy Product and Solutions
2.1.4 Alnylam RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Alnylam Recent Developments and Future Plans
2.2 Sarepta Therapeutics
2.2.1 Sarepta Therapeutics Details
2.2.2 Sarepta Therapeutics Major Business
2.2.3 Sarepta Therapeutics RNAi Therapy Product and Solutions
2.2.4 Sarepta Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sarepta Therapeutics Recent Developments and Future Plans
2.3 Alnylam Pharmaceuticals
2.3.1 Alnylam Pharmaceuticals Details
2.3.2 Alnylam Pharmaceuticals Major Business
2.3.3 Alnylam Pharmaceuticals RNAi Therapy Product and Solutions
2.3.4 Alnylam Pharmaceuticals RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.4 Moderna
2.4.1 Moderna Details
2.4.2 Moderna Major Business
2.4.3 Moderna RNAi Therapy Product and Solutions
2.4.4 Moderna RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Moderna Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi RNAi Therapy Product and Solutions
2.5.4 Sanofi RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 Arcturus Therapeutics
2.6.1 Arcturus Therapeutics Details
2.6.2 Arcturus Therapeutics Major Business
2.6.3 Arcturus Therapeutics RNAi Therapy Product and Solutions
2.6.4 Arcturus Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Arcturus Therapeutics Recent Developments and Future Plans
2.7 Silence
2.7.1 Silence Details
2.7.2 Silence Major Business
2.7.3 Silence RNAi Therapy Product and Solutions
2.7.4 Silence RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Silence Recent Developments and Future Plans
2.8 Sirnaomics
2.8.1 Sirnaomics Details
2.8.2 Sirnaomics Major Business
2.8.3 Sirnaomics RNAi Therapy Product and Solutions
2.8.4 Sirnaomics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sirnaomics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global RNAi Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of RNAi Therapy by Company Revenue
3.2.2 Top 3 RNAi Therapy Players Market Share in 2022
3.2.3 Top 6 RNAi Therapy Players Market Share in 2022
3.3 RNAi Therapy Market: Overall Company Footprint Analysis
3.3.1 RNAi Therapy Market: Region Footprint
3.3.2 RNAi Therapy Market: Company Product Type Footprint
3.3.3 RNAi Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global RNAi Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global RNAi Therapy Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global RNAi Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global RNAi Therapy Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America RNAi Therapy Consumption Value by Type (2018-2029)
6.2 North America RNAi Therapy Consumption Value by Application (2018-2029)
6.3 North America RNAi Therapy Market Size by Country
6.3.1 North America RNAi Therapy Consumption Value by Country (2018-2029)
6.3.2 United States RNAi Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada RNAi Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico RNAi Therapy Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe RNAi Therapy Consumption Value by Type (2018-2029)
7.2 Europe RNAi Therapy Consumption Value by Application (2018-2029)
7.3 Europe RNAi Therapy Market Size by Country
7.3.1 Europe RNAi Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany RNAi Therapy Market Size and Forecast (2018-2029)
7.3.3 France RNAi Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom RNAi Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia RNAi Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy RNAi Therapy Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific RNAi Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific RNAi Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific RNAi Therapy Market Size by Region
8.3.1 Asia-Pacific RNAi Therapy Consumption Value by Region (2018-2029)
8.3.2 China RNAi Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan RNAi Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea RNAi Therapy Market Size and Forecast (2018-2029)
8.3.5 India RNAi Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia RNAi Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia RNAi Therapy Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America RNAi Therapy Consumption Value by Type (2018-2029)
9.2 South America RNAi Therapy Consumption Value by Application (2018-2029)
9.3 South America RNAi Therapy Market Size by Country
9.3.1 South America RNAi Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil RNAi Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina RNAi Therapy Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa RNAi Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa RNAi Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa RNAi Therapy Market Size by Country
10.3.1 Middle East & Africa RNAi Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey RNAi Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia RNAi Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE RNAi Therapy Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 RNAi Therapy Market Drivers
11.2 RNAi Therapy Market Restraints
11.3 RNAi Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 RNAi Therapy Industry Chain
12.2 RNAi Therapy Upstream Analysis
12.3 RNAi Therapy Midstream Analysis
12.4 RNAi Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global RNAi Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global RNAi Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global RNAi Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global RNAi Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Alnylam Company Information, Head Office, and Major Competitors
Table 6. Alnylam Major Business
Table 7. Alnylam RNAi Therapy Product and Solutions
Table 8. Alnylam RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Alnylam Recent Developments and Future Plans
Table 10. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
Table 11. Sarepta Therapeutics Major Business
Table 12. Sarepta Therapeutics RNAi Therapy Product and Solutions
Table 13. Sarepta Therapeutics RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Sarepta Therapeutics Recent Developments and Future Plans
Table 15. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 16. Alnylam Pharmaceuticals Major Business
Table 17. Alnylam Pharmaceuticals RNAi Therapy Product and Solutions
Table 18. Alnylam Pharmaceuticals RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 20. Moderna Company Information, Head Office, and Major Competitors
Table 21. Moderna Major Business
Table 22. Moderna RNAi Therapy Product and Solutions
Table 23. Moderna RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Moderna Recent Developments and Future Plans
Table 25. Sanofi Company Information, Head Office, and Major Competitors
Table 26. Sanofi Major Business
Table 27. Sanofi RNAi Therapy Product and Solutions
Table 28. Sanofi RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Sanofi Recent Developments and Future Plans
Table 30. Arcturus Therapeutics Company Information, Head Office, and Major Competitors
Table 31. Arcturus Therapeutics Major Business
Table 32. Arcturus Therapeutics RNAi Therapy Product and Solutions
Table 33. Arcturus Therapeutics RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Arcturus Therapeutics Recent Developments and Future Plans
Table 35. Silence Company Information, Head Office, and Major Competitors
Table 36. Silence Major Business
Table 37. Silence RNAi Therapy Product and Solutions
Table 38. Silence RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Silence Recent Developments and Future Plans
Table 40. Sirnaomics Company Information, Head Office, and Major Competitors
Table 41. Sirnaomics Major Business
Table 42. Sirnaomics RNAi Therapy Product and Solutions
Table 43. Sirnaomics RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Sirnaomics Recent Developments and Future Plans
Table 45. Global RNAi Therapy Revenue (USD Million) by Players (2018-2023)
Table 46. Global RNAi Therapy Revenue Share by Players (2018-2023)
Table 47. Breakdown of RNAi Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in RNAi Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 49. Head Office of Key RNAi Therapy Players
Table 50. RNAi Therapy Market: Company Product Type Footprint
Table 51. RNAi Therapy Market: Company Product Application Footprint
Table 52. RNAi Therapy New Market Entrants and Barriers to Market Entry
Table 53. RNAi Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global RNAi Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 55. Global RNAi Therapy Consumption Value Share by Type (2018-2023)
Table 56. Global RNAi Therapy Consumption Value Forecast by Type (2024-2029)
Table 57. Global RNAi Therapy Consumption Value by Application (2018-2023)
Table 58. Global RNAi Therapy Consumption Value Forecast by Application (2024-2029)
Table 59. North America RNAi Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 60. North America RNAi Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 61. North America RNAi Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 62. North America RNAi Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 63. North America RNAi Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 64. North America RNAi Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 65. Europe RNAi Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Europe RNAi Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Europe RNAi Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 68. Europe RNAi Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 69. Europe RNAi Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe RNAi Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific RNAi Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 72. Asia-Pacific RNAi Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 73. Asia-Pacific RNAi Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 74. Asia-Pacific RNAi Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 75. Asia-Pacific RNAi Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 76. Asia-Pacific RNAi Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 77. South America RNAi Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 78. South America RNAi Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 79. South America RNAi Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 80. South America RNAi Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 81. South America RNAi Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 82. South America RNAi Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Middle East & Africa RNAi Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 84. Middle East & Africa RNAi Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 85. Middle East & Africa RNAi Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 86. Middle East & Africa RNAi Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 87. Middle East & Africa RNAi Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 88. Middle East & Africa RNAi Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 89. RNAi Therapy Raw Material
Table 90. Key Suppliers of RNAi Therapy Raw Materials
Table 1. Global RNAi Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global RNAi Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global RNAi Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global RNAi Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Alnylam Company Information, Head Office, and Major Competitors
Table 6. Alnylam Major Business
Table 7. Alnylam RNAi Therapy Product and Solutions
Table 8. Alnylam RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Alnylam Recent Developments and Future Plans
Table 10. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
Table 11. Sarepta Therapeutics Major Business
Table 12. Sarepta Therapeutics RNAi Therapy Product and Solutions
Table 13. Sarepta Therapeutics RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Sarepta Therapeutics Recent Developments and Future Plans
Table 15. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 16. Alnylam Pharmaceuticals Major Business
Table 17. Alnylam Pharmaceuticals RNAi Therapy Product and Solutions
Table 18. Alnylam Pharmaceuticals RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 20. Moderna Company Information, Head Office, and Major Competitors
Table 21. Moderna Major Business
Table 22. Moderna RNAi Therapy Product and Solutions
Table 23. Moderna RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Moderna Recent Developments and Future Plans
Table 25. Sanofi Company Information, Head Office, and Major Competitors
Table 26. Sanofi Major Business
Table 27. Sanofi RNAi Therapy Product and Solutions
Table 28. Sanofi RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Sanofi Recent Developments and Future Plans
Table 30. Arcturus Therapeutics Company Information, Head Office, and Major Competitors
Table 31. Arcturus Therapeutics Major Business
Table 32. Arcturus Therapeutics RNAi Therapy Product and Solutions
Table 33. Arcturus Therapeutics RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Arcturus Therapeutics Recent Developments and Future Plans
Table 35. Silence Company Information, Head Office, and Major Competitors
Table 36. Silence Major Business
Table 37. Silence RNAi Therapy Product and Solutions
Table 38. Silence RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Silence Recent Developments and Future Plans
Table 40. Sirnaomics Company Information, Head Office, and Major Competitors
Table 41. Sirnaomics Major Business
Table 42. Sirnaomics RNAi Therapy Product and Solutions
Table 43. Sirnaomics RNAi Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Sirnaomics Recent Developments and Future Plans
Table 45. Global RNAi Therapy Revenue (USD Million) by Players (2018-2023)
Table 46. Global RNAi Therapy Revenue Share by Players (2018-2023)
Table 47. Breakdown of RNAi Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in RNAi Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 49. Head Office of Key RNAi Therapy Players
Table 50. RNAi Therapy Market: Company Product Type Footprint
Table 51. RNAi Therapy Market: Company Product Application Footprint
Table 52. RNAi Therapy New Market Entrants and Barriers to Market Entry
Table 53. RNAi Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global RNAi Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 55. Global RNAi Therapy Consumption Value Share by Type (2018-2023)
Table 56. Global RNAi Therapy Consumption Value Forecast by Type (2024-2029)
Table 57. Global RNAi Therapy Consumption Value by Application (2018-2023)
Table 58. Global RNAi Therapy Consumption Value Forecast by Application (2024-2029)
Table 59. North America RNAi Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 60. North America RNAi Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 61. North America RNAi Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 62. North America RNAi Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 63. North America RNAi Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 64. North America RNAi Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 65. Europe RNAi Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Europe RNAi Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Europe RNAi Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 68. Europe RNAi Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 69. Europe RNAi Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe RNAi Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific RNAi Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 72. Asia-Pacific RNAi Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 73. Asia-Pacific RNAi Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 74. Asia-Pacific RNAi Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 75. Asia-Pacific RNAi Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 76. Asia-Pacific RNAi Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 77. South America RNAi Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 78. South America RNAi Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 79. South America RNAi Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 80. South America RNAi Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 81. South America RNAi Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 82. South America RNAi Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Middle East & Africa RNAi Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 84. Middle East & Africa RNAi Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 85. Middle East & Africa RNAi Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 86. Middle East & Africa RNAi Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 87. Middle East & Africa RNAi Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 88. Middle East & Africa RNAi Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 89. RNAi Therapy Raw Material
Table 90. Key Suppliers of RNAi Therapy Raw Materials
LIST OF FIGURES
Figure 1. RNAi Therapy Picture
Figure 2. Global RNAi Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global RNAi Therapy Consumption Value Market Share by Type in 2022
Figure 4. Small Molecule Interfering Ribonucleic Acid (SiRNA)
Figure 5. Microrna (MiRNA)
Figure 6. Global RNAi Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. RNAi Therapy Consumption Value Market Share by Application in 2022
Figure 8. Oncology Picture
Figure 9. Cardiology Picture
Figure 10. Others Picture
Figure 11. Global RNAi Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global RNAi Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market RNAi Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global RNAi Therapy Consumption Value Market Share by Region (2018-2029)
Figure 15. Global RNAi Therapy Consumption Value Market Share by Region in 2022
Figure 16. North America RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. South America RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. Global RNAi Therapy Revenue Share by Players in 2022
Figure 22. RNAi Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players RNAi Therapy Market Share in 2022
Figure 24. Global Top 6 Players RNAi Therapy Market Share in 2022
Figure 25. Global RNAi Therapy Consumption Value Share by Type (2018-2023)
Figure 26. Global RNAi Therapy Market Share Forecast by Type (2024-2029)
Figure 27. Global RNAi Therapy Consumption Value Share by Application (2018-2023)
Figure 28. Global RNAi Therapy Market Share Forecast by Application (2024-2029)
Figure 29. North America RNAi Therapy Consumption Value Market Share by Type (2018-2029)
Figure 30. North America RNAi Therapy Consumption Value Market Share by Application (2018-2029)
Figure 31. North America RNAi Therapy Consumption Value Market Share by Country (2018-2029)
Figure 32. United States RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe RNAi Therapy Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe RNAi Therapy Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe RNAi Therapy Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 39. France RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific RNAi Therapy Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific RNAi Therapy Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific RNAi Therapy Consumption Value Market Share by Region (2018-2029)
Figure 46. China RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 49. India RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. South America RNAi Therapy Consumption Value Market Share by Type (2018-2029)
Figure 53. South America RNAi Therapy Consumption Value Market Share by Application (2018-2029)
Figure 54. South America RNAi Therapy Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa RNAi Therapy Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa RNAi Therapy Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa RNAi Therapy Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 63. RNAi Therapy Market Drivers
Figure 64. RNAi Therapy Market Restraints
Figure 65. RNAi Therapy Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of RNAi Therapy in 2022
Figure 68. Manufacturing Process Analysis of RNAi Therapy
Figure 69. RNAi Therapy Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. RNAi Therapy Picture
Figure 2. Global RNAi Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global RNAi Therapy Consumption Value Market Share by Type in 2022
Figure 4. Small Molecule Interfering Ribonucleic Acid (SiRNA)
Figure 5. Microrna (MiRNA)
Figure 6. Global RNAi Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. RNAi Therapy Consumption Value Market Share by Application in 2022
Figure 8. Oncology Picture
Figure 9. Cardiology Picture
Figure 10. Others Picture
Figure 11. Global RNAi Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global RNAi Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market RNAi Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global RNAi Therapy Consumption Value Market Share by Region (2018-2029)
Figure 15. Global RNAi Therapy Consumption Value Market Share by Region in 2022
Figure 16. North America RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. South America RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. Global RNAi Therapy Revenue Share by Players in 2022
Figure 22. RNAi Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players RNAi Therapy Market Share in 2022
Figure 24. Global Top 6 Players RNAi Therapy Market Share in 2022
Figure 25. Global RNAi Therapy Consumption Value Share by Type (2018-2023)
Figure 26. Global RNAi Therapy Market Share Forecast by Type (2024-2029)
Figure 27. Global RNAi Therapy Consumption Value Share by Application (2018-2023)
Figure 28. Global RNAi Therapy Market Share Forecast by Application (2024-2029)
Figure 29. North America RNAi Therapy Consumption Value Market Share by Type (2018-2029)
Figure 30. North America RNAi Therapy Consumption Value Market Share by Application (2018-2029)
Figure 31. North America RNAi Therapy Consumption Value Market Share by Country (2018-2029)
Figure 32. United States RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe RNAi Therapy Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe RNAi Therapy Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe RNAi Therapy Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 39. France RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific RNAi Therapy Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific RNAi Therapy Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific RNAi Therapy Consumption Value Market Share by Region (2018-2029)
Figure 46. China RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 49. India RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. South America RNAi Therapy Consumption Value Market Share by Type (2018-2029)
Figure 53. South America RNAi Therapy Consumption Value Market Share by Application (2018-2029)
Figure 54. South America RNAi Therapy Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa RNAi Therapy Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa RNAi Therapy Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa RNAi Therapy Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 63. RNAi Therapy Market Drivers
Figure 64. RNAi Therapy Market Restraints
Figure 65. RNAi Therapy Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of RNAi Therapy in 2022
Figure 68. Manufacturing Process Analysis of RNAi Therapy
Figure 69. RNAi Therapy Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
